These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25436233)

  • 1. Is there a role for probiotics in liver disease?
    Lo RS; Austin AS; Freeman JG
    ScientificWorldJournal; 2014; 2014():874768. PubMed ID: 25436233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and liver diseases.
    Minemura M; Shimizu Y
    World J Gastroenterol; 2015 Feb; 21(6):1691-702. PubMed ID: 25684933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Probiotics in liver diseases].
    Soriano G; Sánchez E; Guarner C
    Nutr Hosp; 2013; 28(3):558-63. PubMed ID: 23848072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut microbiota and the liver: implications for clinical practice.
    Quigley EM; Monsour HP
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):723-32. PubMed ID: 24134195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and probiotics in chronic liver diseases.
    Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
    Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REVIEW- Contemporary evidence on the dynamic role of probiotics in liver diseases.
    Ahmed B; Rasul A; Tareen KZ; Hamid Akash MS; Muhammad SA; Irfan M; Abbas K; Qadir MI
    Pak J Pharm Sci; 2019 Nov; 32(6):2765-2770. PubMed ID: 31969314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and liver disease.
    Sheth AA; Garcia-Tsao G
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S80-4. PubMed ID: 18542037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.
    Qamar AA
    J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of short term treatment with probiotic VSL#3 on various clinical and biochemical parameters in patients with liver cirrhosis.
    Marlicz W; Wunsch E; Mydlowska M; Milkiewicz M; Serwin K; Mularczyk M; Milkiewicz P; Raszeja-Wyszomirska J
    J Physiol Pharmacol; 2016 Dec; 67(6):867-877. PubMed ID: 28195067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study.
    Pereg D; Kotliroff A; Gadoth N; Hadary R; Lishner M; Kitay-Cohen Y
    Nutrition; 2011 Feb; 27(2):177-81. PubMed ID: 20452184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.
    Iacono A; Raso GM; Canani RB; Calignano A; Meli R
    J Nutr Biochem; 2011 Aug; 22(8):699-711. PubMed ID: 21292470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota and the liver.
    Shen TD; Pyrsopoulos N; Rustgi VK
    Liver Transpl; 2018 Apr; 24(4):539-550. PubMed ID: 29316191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?
    Li DY; Yang M; Edwards S; Ye SQ
    JPEN J Parenter Enteral Nutr; 2013 Nov; 37(6):787-93. PubMed ID: 23538296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotic as a novel treatment strategy against liver disease.
    Imani Fooladi AA; Mahmoodzadeh Hosseini H; Nourani MR; Khani S; Alavian SM
    Hepat Mon; 2013 Feb; 13(2):e7521. PubMed ID: 23610585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics in Pediatric Liver Disease.
    Miloh T
    J Clin Gastroenterol; 2015; 49 Suppl 1():S33-6. PubMed ID: 26447962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.